Kate Lawrey | Associate Director, Operations Lead – Asia Next Generation Clinical Development IQVIA | Singapore
Phar-East Day One @ 14:20
Choosing the right country for biosimilars trial
This presentation describes how the access to patient centric real world data helps to provides insights to enable evidenced based, predictive and proactive approach to the management of biosimilars trials. It will also describes the importance of past experience and new insights in trial design, planning and execution to improve the success rate to both sponsor and CRO to bring new biosimilars to market on time to patients in need.